Testing a new device for esophagus treatment
Part of Cancer, Digestive system clinical trials.
This study tests a new device (Digma System) for treating Barrett's esophagus and other esophageal conditions. It involves a short procedure during an endoscopy or surgery to remove abnormal tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are scheduled for esophagus surgery (for cohort A) or endoscopic treatment for Barrett's esophagus (for cohort B).
- If you have Barrett's esophagus, it must be confirmed by biopsy and be 1 to 5 centimeters long.
- You must be able to take oral acid-reducing medication (like Prilosec) if in cohort B.
- You do not have any major medical problems that would make the procedure unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a device that collects cells from the esophagus using a swallowed capsule, which may detect Barrett's esophagus without a standard endoscopy. It is for people who are already scheduled for an endoscopy.
This trial tests a new, non-endoscopic screening method for Barrett's esophagus (a condition that can lead to cancer) in veterans who do not have chronic acid reflux. It aims to find early signs of the condition using a simple swallowable device, potentially avoiding the need for a traditional endoscopy.
This study tests a less invasive way to check for Barrett's esophagus and esophageal cancer. Instead of a standard endoscopy, they may use a sponge-on-a-string or other simpler methods, which could be more comfortable and easier for patients.
This study follows people for 5 years to see how well a new biopsy-mapping test (WATS3D) works during routine upper endoscopy. It may help doctors find Barrett’s esophagus changes earlier and better guide follow-up after treatment.
This study aims to screen for Barrett's esophagus in people who are getting a routine colonoscopy but do not have chronic heartburn. It uses a simple, non-invasive cell collection device (EsoCheck) to see if you might have Barrett's esophagus, which can increase the risk of esophageal cancer.
This study tests less invasive ways to detect high-grade dysplasia (very abnormal cells) and esophageal cancer in people with Barrett's esophagus, a condition that can increase cancer risk. It looks for these changes using cell samples taken during a routine endoscopy, which may be quicker and more comfortable than standard biopsies.
Hear when a new Barrett's Esophagus (BE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.